The clinical variability of Rett syndrome, associated with mutations in the MECP2 gene, varies from classically symptomatic female patients to asymptomatic female patients, and male patients who have none of the diagnostic features considered pathognomonic of this disease. Multiple factors contribute to this variability. In our studies, mutations closer to the amino-terminus, prior to amino acid 255, led to severe clinical manifestations, such as inability to walk, severe dysphagia, and urinary organic acid abnormalities, compared with mutations toward the carboxyl-terminus. However, we found no correlation between severity and mutation type (missense versus nonsense). Despite the importance of mutation location to clinical severity, the widely varying severity within the same mutation suggests that in females, X-chromosome inactivation or other epigenetic phenomena also have roles in determining severity. We propose that stages 1 and 2 of the disease are a consequence of failed, time-linked, postnatal expression of MeCP2 in cerebellar neurons. This, in association with glutamate N-methyl-D-aspartate receptor—mediated neuroexcitotoxic injury to the differentiating neurons, results in the transient age-specific autistic-like behavior, motor, and cognitive dysfunction associated with these stages. (J Child Neurol 2003; 18:662-668).
Get full access to this article
View all access options for this article.
References
1.
Rett A.: [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien Med Wochenschr1966;116:723—726.
2.
Hagberg B., Aicardi J., Dias K., Ramos O.: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett syndrome—Report of 35 cases. Ann Neurol1983;14:471—479.
3.
Naidu S.: Rett syndrome: A disorder affecting early brain growth. Ann Neurol1997;42:3—10.
4.
Amir RE, van den Veyver IB, Wan M., et al: Rett syndrome is caused by mutations in X-linked MeCP2, encoding methyl-CpG-binding protein 2. Nat Genet1999 ;23:185—188.
5.
Sirianni N., Naidu S., Pereira J., et al: Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet1998;63:1552—1558.
6.
Xiang F., Zhang Z., Clarke A., et al: Chromosome mapping of Rett syndrome: A likely candidate region on the telomere of Xq. J Med Genet1998;35:297—300.
7.
Meehan RR, Lewis JD, Bird AP: Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res1992 ;20:5085—5092.
8.
Nan X., Campoy FJ, Bird A.: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell1997;88: 471—481.
9.
Nan X., Ng HH, Johnson CA, et al: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature1998;393:386—389.
10.
Zappella M. , Meloni I., Longo I., et al: Preserved speech variants of the Rett syndrome: Molecular and clinical analysis. Am J Med Genet2001;104:14—22.
11.
Wan M., Lee SS, Zhang X., et al: Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet1999;65:1520—1529.
12.
Hoffbuhr K. , Devaney JM, LaFleur B., et al: MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology2001;56:1486—1495.
13.
Couvert P., Bienvenu T., Aquaviva C., et al: MeCP2 is highly mutated in X-linked mental retardation. Hum Mol Genet2001;10:941—946.
14.
Villard L., Levy N., Xiang F., et al: Segregation of a totally skewed pattern of X chromosome inactivation in four familial cases of Rett syndrome without MECP2 mutation: Implications for the disease. J Med Genet2001;38:435—442.
15.
Villard L., Kpebe A., Cardoso C., et al: Two affected boys in a Rett syndrome family: Clinical and molecular findings. Neurology2000;55:1188—1193.
16.
Bourdon V., Philippe C., Bienvenu T., et al: Evidence of somatic mosaicism for a MECP2 mutation in females with Rett syndrome: Diagnostic implications. J Med Genet2001;38:867—871.
17.
Dotti MT, Orrico A., De Stefano N, et al: A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology2002; 58:226—230.
18.
Schanen C.: Rethinking the fate of males with mutations in the gene that causes Rett syndrome . Brain Dev2001;23(Suppl 1):S144—S146.
19.
Moog U., Smeets EE, van Roozendaal KE, et al: Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). Eur J PaediatrNeurol2003; 7: 5—12.
20.
Jung BP, Jugloff DG, Zhang G., et al: The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol2003;55: 86—96.
21.
Shahbazian MD, Antalffy B., Armstrong DL, Zoghbi HY: Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet2002;11:115—124.
22.
Akbarian S. , Chen RZ, Gribnau J., et al: Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis2001;8:784—791.
23.
Cohen DR, Matarazzo V., Palmer AM, et al: Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci2003;22:417—429.
24.
Hoffbuhr KC , Moses LM, Jerdonek MA, et al: Associations between meCP2 mutations, X-chromosome inactivation, and phenotype. Ment Retard Dev Disabil Res Rev2002;8:99—105.
25.
Bienvenu T. , Villard L., De Roux N., et al: Spectrum of MECP2 mutations in Rett syndrome. Genet Test2002;6:1—6.
26.
De Bona C., Zappella M., Hayek G., et al: Preserved speech variant is allelic of classic Rett syndrome . Eur J Hum Genet2000;8:325—330.
27.
Zappella M. , Meloni I., Longo I., et al: Study of MECP2 gene in Rett syndrome variants and autistic girls. Am J Med Genet2003; 119B: 102—107.
28.
Hagberg B., Witt-Engerström I.: Rett syndrome: A suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet1986;24:47—59.
29.
Trevathan E., Naidu S.: The clinical recognition and differential diagnosis of Rett syndrome. J Child Neurol1988;3(Suppl): S6—S16.
30.
Naidu S., Murphy M., Moser HW, Rett A.: Rett syndrome: Natural history in 70 cases. Am J Med Genet1986;24:61—72.
31.
Leonard H., Bower C.: Is the girl with Rett syndrome normal at birth?Dev Med Child Neurol1998;40:115—121.
32.
Nomura Y., Segawa M.: Clinical features of the early stage of the Rett syndrome. Brain Dev1990; 12:16-19.
33.
Kerr AM: Early clinical signs in the Rett disorder. Neuropediatrics1995;26:67—71.
34.
Bauman ML, Kemper TL: The neuropathology of Rett syndrome is pervasive throughout the brain. Neurology1991;41:306a.
35.
Bauman ML, Kemper TL, Arin DM: Microscopic observations of the brain in Rett syndrome. Neuropediatrics1995;26:105—108.
36.
Johnston MV , Mullaney B., Blue ME: Neurobiology of Rett syndrome. J Child Neurol2003;18:688—692.
37.
Middleton FA , Strick PL: Cerebellar projections to the prefrontal cortex of the primate. J Neurosci2001;21:700—712.
38.
Gebhart AL, Petersen SE, Thach WT: Role of the posterolateral cerebellum in language. Ann N Y Acad Sci2002;978:318—333.
39.
Raymond JL, Lisberger SG, Mauk MD: The cerebellum: A neuronal learning machine?Science1996;272:1126—1231.
40.
Allen G., Courchesne E.: Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: An fMRI study of autism. Am J Psychiatry2003;160: 262—273.
41.
Pierce K., Courchesne E.: Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biol Psychiatry2001;49:655—664.
42.
Townsend J. , Westerfield M., Leaver E., et al: Event-related brain response abnormalities in autism: Evidence for impaired cerebellofrontal spatial attention networks. Brain ResCogn Brain Res2001;11:127—145.
43.
Townsend J. , Courchesne E., Covington J., et al: Spatial attention deficits in patients with acquired or developmental cerebellar abnormality. J Neurosci1999;19:5632—5643.
44.
Kern JK: The possible role of the cerebellum in autism/PDD: Disruption of a multisensory feedback loop. Med Hypotheses2002;59: 255—260.
45.
Oldfors A., Sourander P., Armstrong DL, et al: Rett syndrome: Cerebellar pathology. Pediatr Neurol1990;6:310—314.
46.
Pinto AD, Lang AE, Chen R.: The cerebellothalamocortical pathway in essential tremor. Neurology2003;60:1985—1987.
47.
Dum RP, Strick PL: An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex. J Neurophysiol2003;89:634—639.
48.
Blue ME, Naidu S., Johnston MV: Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol1999;45:541—545.
49.
McDonald JW , Johnston MV: Physiological and pathological roles of excitatory amino acids during central nervous system development. Brain Res1990;15:41—70.
Haas RH, Light M., Rice M., Barshop BA: Oxidative metabolism in Rett syndrome: Clinical studies. Neuropediatrics1995;26: 90—94.
52.
Haas RH, Nasirian F., Hua X., et al: Oxidative metabolism in Rett syndrome: Biochemical and molecular studies. Neuropediatrics1995;26:95—99.
53.
Coker SB, Melnyk AR: Rett syndrome and mitochondrial enzyme deficiencies. J Child Neurol1991;6:164—166.
54.
Meng H., Pan H., Qi Y.: Role of mitochondrial lesion in pathogenesis of sporadic Rett syndrome. Zhonghua Yi Xue Za Zhi2001;81: 662—664.
55.
Jaenisch R. , Bird A.: Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet2003;33(Suppl):245—254.
56.
Naidu S., Chatterjee S., Murphy M., et al: Rett syndrome: New observations. Brain Dev1987;9:525—528.
57.
Motil KJ, Schultz RJ, Browning K., et al: Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr1999;29: 31—37.
58.
Julu PO, Kerr AM, Apartopoulos F., et al: Characterization of breathing and associated central autonomic dysfunction in the Rett disorder. Arch Dis Child2001;85:29—37.
59.
Julu PO, Kerr AM, Hansen S., et al: Functional evidence of brain stem immaturity in Rett syndrome. Eur ChildAdolesc Psychiatry1997;6(Suppl 1):47—54.
Monti B., Marri L., Contestabile A.: NMDA receptor-dependent CREB activation in survival of cerebellar granule cells during in vivo and in vitro development. Eur J Neurosci2002;16:1490—1498.
62.
Petralia RS , Wang YX, Wenthold RJ: NMDA receptors and PSD-95 are found in attachment plaques in cerebellar granular layer glomeruli. Eur J Neurosci2002;15:583—587.
63.
Henneberry RC: The role of neuronal energy in the neurotoxicity of excitatory amino acids. Neurobiol Aging1989;10:611—613; discussion 618—620.
64.
Strauss KI, Marini AM: Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death. J Neurotrauma2002;19:627—638.
65.
Rossi F., Saggiorato C., Strata P.: Target-specific innervation of embryonic cerebellar transplants by regenerating olivocerebellar axons in the adult rat. Exp Neurol2002;173:205—212.
66.
Weimann JM, Charlton CA, Brazelton TR, et al: Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci U S A2003;100:2088—2093.
67.
Kaemmerer WF , Low WC: Cerebellar allografts survive and transiently alleviate ataxia in a transgenic model of spinocerebellar ataxia type-1. Exp Neurol1999;158:301—311.
68.
Tolbert DL, Heckroth J.: Purkinje cell transplants in Shaker mutant rats with hereditary Purkinje cell degeneration and ataxia. Exp Neurol1998;153:255—267.
69.
Amir RE, van den Veyver IB, Schultz R., et al: Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol2000;47:670—679.
70.
Yusufzai TM , Wolffe AP: Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res2000;28: 4172—4179.
71.
Cheadle JP, Gill H., Fleming N., et al: Long-read sequence analysis of the MeCP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and location . Hum Mol Genet2000;9:1119—1129.
72.
Huppke P., Held M., Hanefeld F., et al: Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics2002;33:63—68.
73.
Ballestar E. , Yusufzai TM, Wolffe AP: Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry2000;39:7100—7106.
74.
Kudo S., Nomura Y., Segawa M., et al: Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev2001;23(Suppl 1):S165—S173.
75.
Singer HS, Naidu S.: Rett syndrome: “We'll keep the genes on for you.” Neurology2001;56:582—584.
76.
Armstrong J. , Aibar E., Pineda M., et al: Prenatal diagnosis in Rett syndrome . Fetal Diagn Ther2002;17:200—204.
